Degenerative Disorders Flashcards
Delirium - Definition
AKA acute confusional state, toxic-metabolic encephalopathy
An acute disorder of attention characterized by an inability to maintain a coherent line of thought; reflects diffuse brain dysfunction related to a disruption of normal brain homeostasis, affecting arousal systems in the brainstem, diencephalon, and cortical regions
Delirium - etiology
Drugs - Intoxication and withdrawal Environmental toxins Metabolic disorders Infection Inflammation Structural lesions - TBI, stroke Seizure disorders
Evaluation of delirium
History
Physical exam, including neurologic exam (no MSE)
Labs - CMP, CBC, urinalysis, urine toxicology
ECG, Chest X Ray
CT/MRI of brain
LP if brain infection is suspected
EEG if non-convulsive status epilepticus is suspected
Dementia - definition
An acquired and persistent impairment in intellectual function with deficits in at least 3 areas - memory, language, visuospatial skills, emotion, personality, and complex cognition - which interferes with social and occupational activities
Reversible causes of dementia
Account for 10-20% of dementias
Drugs & Toxins Mass lesions Hypothyroidism Vitamin B12 deficiency Neurosyphilis CNS inflammatory diseases Severe depression Mild TBI
Irreversible Causes of dementia
Accounts for 80-90% of dementias
Alzheimer's Frontotemporal Dementia (FTD) Huntington's Disease Parkinson's Disease Lewy Body Dementia Creutzfeldt-Jakob Disease Multiple Sclerosis HIV-associated dementia Severe TBI
Evaluation of dementia
History
Physical, including neurologic exam and MSE
Labs - CMP, CBC, TSH, B12, RPR (syphilis)
Imaging - MRI or CT of brain
Cortical Dementia - 2 examples
Alzheimer's Disease Frontotemporal Dementia (FTD)
Alzheimer’s Disease - Clinical features
Most common cause of dementia in older people (50-70% of cases); survival after onset is 6-12 years
Stages of Alzheimer’s Disease
Stage I (1-2 years): Notable amnesia
Stage II (2-10 years): Obvious dementia
Stage III (8-12 years): Severe mental and physical incapacity
Mild Cognitive Impairment (MCI)
A transitional stage between normal aging and AD; in a person over 65 with MCI, the conversion rate to AD is 10-15% per year
Alzheimer’s - Neuropathology
Gross - cerebral atrophy, reflecting loss of cortical neurons and synapses
Microscopic - neuritic (amyloid) plaques and neurofibrillary tangles
Genetic risk for early onset Alzheimer’s
Down syndrome (via trisomy of APP gene on chromosome 21); other mutations of APP
Mutations in Presenilin-1 on Chromosome 14
Mutations in Presenilin-2 on Chromosome 1
Genetic Risk - Late onset Alzheimer’s
Epsilon-4 allele of the apolipoprotein E (APOE) gene
Alzheimer’s - Treatment
Acetylcholinesterase inhibitors - Donepezil, Rivastigmine, Galantamine
NMDA antagonist - Memantine